Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)
Condition(s):Cutaneous LeishmaniasisLast Updated:April 9, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Cutaneous LeishmaniasisLast Updated:April 9, 2020Completed
Condition(s):Visceral LeishmaniasisLast Updated:January 14, 2020Completed
Condition(s):Mucocutaneous LeishmaniasisLast Updated:September 4, 2020Completed
Condition(s):Mucocutaneous LeishmaniasisLast Updated:March 4, 2019Completed
Condition(s):Disseminated LeishmaniasisLast Updated:January 1, 2014Completed
Condition(s):Cutaneous Leishmaniases; Treatment Adherence; Primary Health Care; Drug EvaluationLast Updated:August 9, 2022Not yet recruiting
Condition(s):Cutaneous LeishmaniasisLast Updated:June 20, 2012Completed
Condition(s):Visceral LeishmaniasisLast Updated:March 16, 2018Completed
Condition(s):Cutaneous LeishmaniasisLast Updated:May 30, 2017Completed
Condition(s):Visceral LeishmaniasisLast Updated:September 12, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.